Takeda, Par, Watson, Amneal Conspired to Suppress Competition for Generic Gout Treatment, Class Action Claims
August 9, 2021 Another class action alleges Takeda and Par have conspired to suppress competition in the generic drug market, this time for Colcrys (colchicine).